VTRS - 'Airbnb Has Foundational Cracks' Disney+ Follows Netflix On Subscription Sharing Crackdown Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories | Benzinga

October, 03 2023 02:11 PM Viatris Inc.

Benzinga

In a significant development, Microsoft Corp's (NASDAQ: MSFT) CEO, Satya Nadella, has voiced concerns over the competitive landscape of content acquisition essential for training artificial intelligence (AI).
Nadella's remarks came during his testimony in a landmark antitrust trial in the U.S., where he highlighted the challenges posed by exclusive deals that tech giants, notably Alphabet Inc (NASDAQ: GOOGL) (NASDAQ: GOOG) Google, are securing with publishers.

AstraZeneca Plc (NASDAQ: AZN) has agreed to pay $425 million to settle U.S. lawsuits related to heartburn and stomach acid treatments Nexium and Prilosec.
The heartburn treatments have been under litigation, as some users said they caused kidney damage.

Sanofi SA (NASDAQ: SNY) struck a deal with Janssen Pharmaceuticals, a unit of Johnson & Johnson (NYSE: JNJ), to develop and commercialize the vaccine candidate for extraintestinal pathogenic E. coli (9-valent).
Sanofi will pay J&J's Janssen unit $175 million upfront and development and commercial milestones. Both will co-fund research and development costs. The vaccine is in late-stage clinical trials.

Following discussions with the FDA, Takeda Pharmaceutical Co Ltd (NYSE: TAK) will voluntarily withdraw Exkivity (mobocertinib) in the U.S.
Takeda intends to similarly initiate voluntary withdrawal globally where Exkivity is approved and is working with regulators in other countries where it is currently available on the next steps.

Target Corp (NYSE: TGT) has kicked off the holiday toy shopping season by offering thousands of affordable, trendy toys and games under $25 across its broad assortment.
The retailer has also unveiled its affordable Bullseye's Top Toys list and new exclusives through collaborations.

McCormick & Company, Incorporated (NYSE: MKC) reported third-quarter FY23 sales growth of 6% year-on-year to $1.684 billion, missing ...